期刊文献+

抗癌药物奥沙利铂的合成研究进展 被引量:6

A Development on Synthesis of Anti-cancer Oxaliplatin
下载PDF
导出
摘要 奥沙利铂是一种新型的抗肿瘤药物,对多种癌种有效。本文介绍了奥沙利铂的化学合成方法,对国内外主要研究方法进行了分析,研究了国内外的发展趋势。避开国外专利保护范围,设计出一条新的合成路线并探讨了该工艺的可行性,简要介绍了奥沙利铂在医药方面的应用。 Oxaliplatin is a new anticancer drug that has good inhibitive effect on cancers. Synthesis and analysis of oxaliplatin were introduced, and a trend on oxaliplatin was reviewed. A new method for synthesis of oxaliplatin was designed to avoid the intellectual property right problem, and the feasibility of the method was discussed. Finally, the application of oxaliplatin in medicine was introduced briefly.
出处 《精细化工中间体》 CAS 2006年第1期18-20,共3页 Fine Chemical Intermediates
关键词 奥沙利铂 合成 收率 纯度 oxaliplatin synthesis yield purity
  • 相关文献

参考文献9

  • 1普绍平,杨懿焜,高文桂,余尧,刘伟平.草酸铂的合成及其结构表征[J].贵金属,2000,21(1):26-27. 被引量:18
  • 2高文桂,普绍平,等.草酸铂的水合反应动力学[J].有色金属,2002,54(B07):224-227. 被引量:3
  • 3Kidani Y, Inagaki K. Cis-platinum (Ⅱ) complex of trans-l-1,2-diaminocyclohexane[P]. US4169846, 1979-10-02.
  • 4Tozawa, Takeshi. Optically pure cis-oxalato (trans-1-1,2-cyclohexanediamine) Pt (Ⅱ) and process for resolving optical isomers of platinum complex compound [P]. EP0567438A1, 1993-10-27.
  • 5Taniuchi, Junichi. Process of preparing platinum compound [P].EP 0801070A2, 1997-10-15.
  • 6Okamoto, Koji.Platinum compound and pross of preparing same[P]. EP 0617043A1, 1994-09-28
  • 7Okamoto, Koji, Nakanishi, et. al. Process of preparing a cis-oxalato (trans-l- 1,2-cyclohexanediamine) Pt(Ⅱ) complex having high optical purity[P]. EP 0625523B1, 2001-10-31.
  • 8Markus G, Afshin Y, Michael A.J, et al. Synthesis,cytotoxicity, andstrueture-activity relationships of new oxaliplatin derivatives[J]. Monatshefte for chemie.2005, 136:693 -695.
  • 9尤启东,林国强.手性药物-研究与应用[M].北京:化学工业出版社.2004.597-598.

二级参考文献12

共引文献25

同被引文献34

  • 1任鹏,孙坚彤,沈云玉,黄彩英.反相高效液相色谱法测定奥沙利铂的含量[J].抗感染药学,2005,2(1):24-24. 被引量:17
  • 2张红梅,李晓霞,关玉梅,唐向芹,李强.奥沙利铂联合亚叶酸钙和氟尿嘧啶治疗晚期大肠癌的临床观察[J].临床肿瘤学杂志,2005,10(5):494-496. 被引量:19
  • 3李明颖,徐建明,宋三泰.奥沙利铂的神经毒性机理与防治方法研究进展[J].中华医学杂志,2006,86(19):1365-1367. 被引量:40
  • 4Kelly H, Goldberg RM. Systemic therapy for metastatic eoloreetal eancer:currentoptions, current evidence[J]. J Clin Oncol, 2005,23(20) :4553 -4560.
  • 5Aggarwal S, Chu E. Current therapies for advanced colorectal cancer[J]. Oncology(Williston Park), 2005,19(5): 589-595.
  • 6Hengartner MO. The biochemistry of apoptosis[J]. Nature, 2000,407 (12) : 770-776.
  • 7Haviv R, Lindenbom L, Li H, et al. Need for caspases in apoptosis of trophic factor-deprived PCI2 cells[J]. J Neuronsci Res, 1997,50(1):69-80.
  • 8Springer JE, Azbill RD, Knapp PE. Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury[J]. Nature Med, 1999,5(8):943-946.
  • 9Nicholas J, Santos AS, Eric D, et al.Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death[J]. Nature, 2001, 410(6828):549 - 554.
  • 10Tozawa T,Komoda Y,Chnishi J,el al.Optically pure cis-oxalato (trans-1-1,2-cyclohexanediamine) Pt (Ⅱ) and process for resolving optical isomers of a platinum complex compound:EP,0567438[P].1993-04-09.

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部